Research and development
Flow – sum over the period · $M
Q2 2026
117$M
All values (10)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 117 | reported |
| Q1 2026 | 104 | reported |
| Q4 2025 | 109 | derived |
| Q3 2025 | 93 | reported |
| Q2 2025 | 80 | reported |
| Q1 2025 | 70 | reported |
| Q4 2024 | 21 | derived |
| Q3 2024 | 14 | reported |
| Q2 2024 | 12 | reported |
| Q1 2024 | 9 | reported |
| Q1 2016 – Q4 2023 | – | missing (32 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: rnd
More metrics for CoreWeave
Income statement
Balance sheet
Debt and interest
Sources & calculation
- Value
- $117M
- Period
- Q2 2026, ended Jun 30, 2026 · quarterly value (3 months, not cumulative)
- Source
- 10-Q, filed Aug 12, 2026 · 0001769628-26-000366
- Location
- us-gaap:ResearchAndDevelopmentExpense
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $117M | Aug 12, 2026 | 10-Q 0001769628-26-000366 | reported · confidence 1. · current |